Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Common Equity (2018 - 2025)

Inventiva (IVA) posted quarterly Common Equity of -$33.2 million for Q4 2025, up 70.87% year-over-year from -$19.4 million in Q4 2024, and up 99.67% quarter-over-quarter from -$10.1 billion in Q2 2025.

Analysis

Inventiva (IVA) Common Equity (2018 - 2025) Analysis & Trends

Inventiva's Common Equity history runs 8 years deep, the most recent figure standing at -$33.2 million for Q4 2025.

  • In Q4 2025, Common Equity rose 70.87% year-over-year to -$33.2 million; the TTM figure through Dec 2025 stood at -$33.2 million (up 70.87% YoY), while the FY2025 annual figure was -$33.2 million, up 70.87% from the prior year.
  • Common Equity for Q4 2025 stood at -$33.2 million, up from -$10.1 billion in the prior quarter.
  • The five-year high for Common Equity was $74.4 billion in Q2 2022, with the low at -$10.1 billion in Q2 2025.
  • The 5-year median for Common Equity is $8.1 million (2023), against an average of $5.4 billion.
  • The sharpest annual moves came in 2022 and 2025: Common Equity surged 69694.74% in 2022, then plunged 11744.94% in 2025.
  • Inventiva's Common Equity stood at $101.7 million in 2021, then plunged by 54.36% to $46.4 million in 2022, then sank by 174.28% to -$34.5 million in 2023, then tumbled by 230.67% to -$114.0 million in 2024, then soared by 70.87% to -$33.2 million in 2025.
  • Business Quant data shows IVA's Common Equity at -$33.2 million in Q4 2025, -$10.1 billion in Q2 2025, and -$114.0 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.42 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 6.76 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.61 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.17 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.35 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.79 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 757.49 Mn
10 Inventiva 893.85 Mn 893.85 Mn - -33.20 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -33.20 Bn
Jun 30, 2025 -10.08 Mn
Dec 31, 2024 -113.96 Mn
Jun 30, 2024 -85.14 Mn
Dec 31, 2023 -34.46 Mn
Jun 30, 2023 -8.35 Mn
Dec 31, 2022 46.40 Mn
Jun 30, 2022 74.40 Mn
Dec 31, 2021 101.66 Mn
Jun 30, 2021 106.60 Mn
Mar 31, 2021 123.34 Mn
Dec 31, 2020 132.60 Mn
Jun 30, 2020 45.97 Mn
Dec 31, 2019 45.82 Mn
Dec 31, 2018 70.31 Mn